|
|
Volumn 85, Issue , 2003, Pages 79-86
|
|
Use of tumor-activated hepatic stellate cell as a target for the preclinical testing of anti-angiogenic drugs against hepatic tumor development.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ENDOTHELIAL CELL GROWTH FACTOR;
GROWTH PROMOTOR;
LYMPHOKINE;
SIGNAL PEPTIDE;
TUMOR PROTEIN;
VASCULOTROPIN;
VASCULOTROPIN A;
ANIMAL;
APOPTOSIS;
CELL CULTURE;
CULTURE MEDIUM;
DRUG EFFECT;
DRUG SCREENING;
LIVER TUMOR;
MALE;
METASTASIS;
MOUSE;
NEOVASCULARIZATION (PATHOLOGY);
PATHOLOGY;
PERICYTE;
REVIEW;
SECRETION;
TRANSPLANTATION;
VASCULAR ENDOTHELIUM;
ANGIOGENESIS INHIBITORS;
ANIMALS;
APOPTOSIS;
CELLS, CULTURED;
CULTURE MEDIA, CONDITIONED;
DRUG SCREENING ASSAYS, ANTITUMOR;
ENDOTHELIAL GROWTH FACTORS;
ENDOTHELIUM, VASCULAR;
GROWTH SUBSTANCES;
INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS;
LIVER NEOPLASMS, EXPERIMENTAL;
LYMPHOKINES;
MALE;
MICE;
NEOPLASM PROTEINS;
NEOVASCULARIZATION, PATHOLOGIC;
PERICYTES;
TUMOR CELLS, CULTURED;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VASCULAR ENDOTHELIAL GROWTH FACTORS;
|
|
EID: 0037942905
PISSN: 15431894
EISSN: None
Source Type: Journal
DOI: 10.1385/1-59259-380-1:79 Document Type: Review |
|
Times cited : (3)
|
|
References (16)
|
